Skip to main content
OCUL
NASDAQ Life Sciences

Ocular Therapeutix Posts $94.8M Third-Quarter Loss

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$6.59
Mkt Cap
$1.448B
52W Low
$6
52W High
$16.44
52W Position info
9.8% above low
Off High info
60% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

OCUL is trading near its 52-week low of $6 (9.8% above the low).

Summary

Ocular Therapeutix reported a $94.8 million net loss for the third quarter. That is a steep figure for a company of this size and continues the pattern of rising losses and cash burn flagged in the last 10-Q, which showed a larger Q2 loss alongside a plan to file the AXPAXLI NDA in wet AMD in Q4 2026. The loss likely reflects heavy spending on the AXPAXLI program ahead of that submission rather than an operational surprise, but the headline number alone gives no revenue, per-share or cash balance detail. The key question is whether the company reaffirmed its cash runway into 2028 and the Q4 2026 NDA timeline. Watch the AXPAXLI NDA submission, expected in Q4 2026.

At the time of this announcement, OCUL was trading at $6.59 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $6.00 to $16.44. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

OCUL - Latest Insights

OCUL
Nov 09, 2026, 7:19 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $6.20
Real-time Price: $6.25 info
Change: +$0.050 (+0.81%) info
Market Cap: $1.448B info
OCUL
Nov 09, 2026, 7:08 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.06
Real-time Price: $6.25 info
Change: +$0.1902 (+3%) info
Market Cap: $1.448B info
OCUL
Sep 15, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $10.76
Real-time Price: $6.25 info
Change: -$4.51 (-42%) info
Market Cap: $1.448B info
OCUL
Aug 03, 2026, 7:16 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $8.27
Real-time Price: $6.25 info
Change: -$2.02 (-24%) info
Market Cap: $1.448B info
OCUL
Aug 03, 2026, 7:07 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.35
Real-time Price: $6.25 info
Change: -$2.10 (-25%) info
Market Cap: $1.448B info